Biogen to Present at the Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Morgan Stanley Global Healthcare Conference. The webcast will be live on Monday, September 12, 2016 at 1:40p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.

About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160901005872/en/

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Source: Biogen Inc.

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Biogen (BIIB)
• Best AI Productivity Tools for Creators (2026): CapCut Recognized for Faster Video and Image Workflows by Software Experts
• ACE ROBOTICS Unveils Kairos 3.1 and Expands Its Embodied AI Stack from Data to Deployment at WAIC 2026